Esperion Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 39.77. In total, the insiders bought 10.51M and sold 314.74K ESPR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
39.77
Buy 10.51M shares
Sell 314.74K shares
62% Buy Activity
Negligible or No Correlation
Buy Signal Medium Confidence
Mar 13, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 39.77.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 28, 2026
Buy
Common Stock
A-Award
Carroll J Martin
Director
Director 79 873
Value: $250.0K
May 28, 2026
Buy
Common Stock
A-Award
Fischer Seth H. Z.
Director
Director 79 873
Value: $250.0K
May 28, 2026
Buy
Common Stock
A-Award
Thompson John Craig
Director
Director 79 873
Value: $250.0K
May 28, 2026
Buy
Common Stock
A-Award
Shepard Jay
Director
Director 79 873
Value: $250.0K
May 28, 2026
Buy
Common Stock
A-Award
Hoffman Robert E.
Director
Director 79 873
Value: $250.0K
Mar 17, 2026
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 6 424
Value: $17.4K
Mar 17, 2026
Sell
Common Stock
S-Sale
Koenig Sheldon L.
President And CEO
CEO / President 25 578
Value: $69.5K
Mar 17, 2026
Sell
Common Stock
S-Sale
Looker Benjamin
Chief Legal Officer
Officer 5 708
Value: $15.4K
Mar 13, 2026
Buy
Common Stock
A-Award
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 247 430
Value: $603.7K
Mar 13, 2026
Buy
Common Stock
A-Award
Koenig Sheldon L.
President And CEO
CEO / President 723 760
Value: $1.77M
Mar 13, 2026
Buy
Common Stock
A-Award
Looker Benjamin
Chief Legal Officer
Officer 300 840
Value: $734.0K
Mar 13, 2026
Buy
Stock Option (right to buy)
A-Award
Looker Benjamin
Chief Legal Officer
Officer 269 230
Value: $656.9K
Mar 13, 2026
Buy
Stock Option (right to buy)
A-Award
Koenig Sheldon L.
President And CEO
CEO / President 647 460
Value: $1.58M
Mar 13, 2026
Buy
Stock Option (right to buy)
A-Award
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 221 270
Value: $539.9K
Jan 20, 2026
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 1 689
Value: $5K
Dec 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 6 517
Value: $23.9K
Dec 17, 2025
Sell
Common Stock
S-Sale
Koenig Sheldon L.
President And CEO
CEO / President 48 244
Value: $177.2K
Dec 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 7 337
Value: $26.9K
Dec 04, 2025
Buy
Common Stock
A-Award
Harlow John B. Jr.
Chief Commercial Officer
Officer 424 536
Value: $1.61M
Dec 04, 2025
Buy
Stock Option (right to buy)
A-Award
Harlow John B. Jr.
Chief Commercial Officer
Officer 380 000
Value: $1.44M
Nov 17, 2025
Buy
Common Stock
J-Other
Harlow John B. Jr.
Officer
Officer 0
Value: $0
Sep 17, 2025
Sell
Common Stock
S-Sale
Looker Benjamin
General Counsel
Officer 6 267
Value: $17.6K
Sep 17, 2025
Sell
Common Stock
S-Sale
Koenig Sheldon L.
President And CEO
CEO / President 28 427
Value: $79.3K
Sep 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 7 046
Value: $19.8K
Sep 17, 2025
Sell
Common Stock
S-Sale
Halladay Benjamin
Chief Financial Officer
C-Suite Officer 7 046
Value: $19.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE